Search results
Results from the WOW.Com Content Network
The COVID-19 pandemic in Kenya was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have reached Kenya on 12 March 2020, [3] with the initial cases reported in the capital city Nairobi and in the coastal area Mombasa .
April 11, 2024 at 12:09 PM. (Reuters) -Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for COVID-19 ...
Main article: COVID-19 pandemic in Mozambique. The country's first case was announced on 22 March, a 75-year-old man who returned from the United Kingdom. [109] Mozambique reported 23,726 total cases, 5,239 active cases, and 205 total deaths on 13 January 2021. This is 39 deaths per one million population.
This is a general overview and status of places affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus which causes coronavirus disease 2019 and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 were identified in Wuhan, the capital of the province of Hubei in China in December 2019.
COVID-19 portal. v. t. e. The COVID-19 pandemic was confirmed to have spread to Africa on 14 February 2020, with the first confirmed case announced in Egypt. [2] [3] The first confirmed case in sub-Saharan Africa was announced in Nigeria at the end of February 2020. [4]
Kenya had an estimated 5 million malaria cases and over 12,000 deaths reported in 2022, according to the World Health Organization. Most of those affected are children under 5 and pregnant women.
For the Netherlands, based on overall excess mortality, an estimated 20,000 people died from COVID-19 in 2020, [9] while only the death of 11,525 identified COVID-19 cases was registered. [8] The official count of COVID-19 deaths as of December 2021 is slightly more than 5.4 million, according to World Health Organization's report in May 2022.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...